Page last updated: 2024-10-31

deoxyepinephrine and Ventricular Dysfunction, Left

deoxyepinephrine has been researched along with Ventricular Dysfunction, Left in 2 studies

Deoxyepinephrine: Sympathomimetic, vasoconstrictor agent.

Ventricular Dysfunction, Left: A condition in which the LEFT VENTRICLE of the heart was functionally impaired. This condition usually leads to HEART FAILURE; MYOCARDIAL INFARCTION; and other cardiovascular complications. Diagnosis is made by measuring the diminished ejection fraction and a depressed level of motility of the left ventricular wall.

Research Excerpts

ExcerptRelevanceReference
"Ibopamine has varying degrees of affinity for these various families, being the highest for the dopamine receptors and the lowest for the alpha adrenergic receptors."2.39Neurohormonal and hemodynamic effects of ibopamine. ( Pouleur, H, 1995)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pouleur, H1
Hillege, HL1
Girbes, AR1
de Kam, PJ1
Boomsma, F1
de Zeeuw, D1
Charlesworth, A1
Hampton, JR1
van Veldhuisen, DJ1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Efficacy of Intravenous Levosimendan Compared With Dobutamine on Renal Hemodynamics and Function in Chronic Heart Failure[NCT02133105]Phase 333 participants (Actual)Interventional2014-04-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for deoxyepinephrine and Ventricular Dysfunction, Left

ArticleYear
Neurohormonal and hemodynamic effects of ibopamine.
    Clinical cardiology, 1995, Volume: 18, Issue:3 Suppl I

    Topics: Clinical Trials as Topic; Deoxyepinephrine; Dopamine Agonists; Heart Failure; Hemodynamics; Humans;

1995

Trials

1 trial available for deoxyepinephrine and Ventricular Dysfunction, Left

ArticleYear
Renal function, neurohormonal activation, and survival in patients with chronic heart failure.
    Circulation, 2000, Jul-11, Volume: 102, Issue:2

    Topics: Aged; Aldosterone; Atrial Natriuretic Factor; Cardiac Output; Cardiotonic Agents; Catecholamines; Ch

2000